Commonwealth of Pennsylvania Public School Empls Retrmt SYS Increases Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 9.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 190,012 shares of the company’s stock after buying an additional 16,792 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS owned 0.09% of Cellebrite DI worth $4,186,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the stock. Quarry LP purchased a new position in shares of Cellebrite DI in the third quarter valued at approximately $27,000. Advisors Asset Management Inc. boosted its stake in shares of Cellebrite DI by 130.5% in the third quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock valued at $52,000 after purchasing an additional 1,742 shares during the period. R Squared Ltd purchased a new position in shares of Cellebrite DI in the fourth quarter valued at approximately $100,000. Polen Capital Management LLC purchased a new position in shares of Cellebrite DI in the fourth quarter valued at approximately $222,000. Finally, Victory Capital Management Inc. acquired a new stake in Cellebrite DI in the fourth quarter valued at approximately $234,000. Hedge funds and other institutional investors own 45.88% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their target price on shares of Cellebrite DI from $24.00 to $28.00 and gave the company an “overweight” rating in a report on Tuesday, February 11th. Lake Street Capital raised their target price on shares of Cellebrite DI from $17.00 to $26.00 and gave the company a “buy” rating in a report on Friday, February 14th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $28.00 target price on shares of Cellebrite DI in a report on Monday, March 10th. Seven investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Cellebrite DI currently has a consensus rating of “Buy” and a consensus target price of $23.43.

Cellebrite DI Trading Up 1.0 %

CLBT stock opened at $19.23 on Monday. Cellebrite DI Ltd. has a twelve month low of $10.25 and a twelve month high of $26.30. The company’s 50 day moving average is $21.12 and its two-hundred day moving average is $19.80. The stock has a market cap of $4.61 billion, a P/E ratio of -13.83, a PEG ratio of 4.27 and a beta of 1.52.

Cellebrite DI (NASDAQ:CLBT) last announced its earnings results on Thursday, February 13th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Cellebrite DI had a negative net margin of 70.54% and a positive return on equity of 58.70%. On average, equities research analysts predict that Cellebrite DI Ltd. will post 0.3 earnings per share for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.